Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Related Citations for PubMed (Select 22010391)

1.

Cytoreductive surgery for advanced ovarian cancer: quo vadis?

Schorge JO, Garrett LA, Goodman A.

Oncology (Williston Park). 2011 Sep;25(10):928-34. Review.

2.

Surgical debulking of ovarian cancer: what difference does it make?

Schorge JO, McCann C, Del Carmen MG.

Rev Obstet Gynecol. 2010 Summer;3(3):111-7.

3.

Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.

Morrison J, Haldar K, Kehoe S, Lawrie TA.

Cochrane Database Syst Rev. 2012 Aug 15;8:CD005343. doi: 10.1002/14651858.CD005343.pub3. Review.

4.

Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.

Morrison J, Swanton A, Collins S, Kehoe S.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005343. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD005343.

PMID:
17943850
5.

Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study.

van de Laar R, Zusterzeel PL, Van Gorp T, Buist MR, van Driel WJ, Gaarenstroom KN, Arts HJ, van Huisseling JC, Hermans RH, Pijnenborg JM, Schutter EM, Pelikan HM, Vollebergh JH, Engelen MJ, Inthout J, Kruitwagen RF, Massuger LF.

BMC Cancer. 2014 Jan 14;14:22. doi: 10.1186/1471-2407-14-22.

6.

Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.

Vergote I, Amant F, Kristensen G, Ehlen T, Reed NS, Casado A.

Eur J Cancer. 2011 Sep;47 Suppl 3:S88-92. doi: 10.1016/S0959-8049(11)70152-6. Review.

PMID:
21944035
7.

Primary cytoreductive surgery for advanced ovarian cancer: is it the past, present, or future?

Schorge JO, Bradford LS, del Carmen MG.

Clin Adv Hematol Oncol. 2011 Dec;9(12):912-8. Review.

PMID:
22252659
8.

Interval debulking surgery for advanced epithelial ovarian cancer.

Tangjitgamol S, Manusirivithaya S, Laopaiboon M, Lumbiganon P, Bryant A.

Cochrane Database Syst Rev. 2010 Oct 6;(10):CD006014. doi: 10.1002/14651858.CD006014.pub5. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD006014.

PMID:
20927744
9.

Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.

Vergote IB, De Wever I, Decloedt J, Tjalma W, Van Gramberen M, van Dam P.

Semin Oncol. 2000 Jun;27(3 Suppl 7):31-6.

PMID:
10952124
10.

Interval debulking surgery for advanced epithelial ovarian cancer.

Tangjitgamol S, Manusirivithaya S, Laopaiboon M, Lumbiganon P.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006014. doi: 10.1002/14651858.CD006014.pub4. Review. Update in: Cochrane Database Syst Rev. 2010;(10):CD006014.

PMID:
19370622
11.

Interval debulking surgery for advanced epithelial ovarian cancer.

Tangjitgamol S, Manusirivithaya S, Laopaiboon M, Lumbiganon P.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006014. doi: 10.1002/14651858.CD006014.pub3. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD006014.

PMID:
19160263
12.

Surgical cytoreduction for recurrent epithelial ovarian cancer.

Al Rawahi T, Lopes AD, Bristow RE, Bryant A, Elattar A, Chattopadhyay S, Galaal K.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD008765. doi: 10.1002/14651858.CD008765.pub3. Review.

PMID:
23450588
13.

Clinical outcome of Iranian patients with advanced ovarian cancer with neoadjuvant chemotherapy versus primary debulking surgery.

Ghaemmaghami F, Karimi-Zarchi M, Modares-Gilani M, Mousavi A, Behtash N.

Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):719-24.

14.

[Neoadjuvant chemotherapy and ovarian cancer].

Ray-Coquard I, Saba C, Bachelot T, Méeus P, Mignotte H, Blondet R, Treilleux I, Peix M, Guastalla JP.

Bull Cancer. 2006 Jul;93(7):669-76. Review. French.

PMID:
16873075
15.

Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.

Colombo PE, Mourregot A, Fabbro M, Gutowski M, Saint-Aubert B, Quenet F, Gourgou S, Rouanet P.

Eur J Surg Oncol. 2009 Feb;35(2):135-43. doi: 10.1016/j.ejso.2008.01.005. Epub 2008 Mar 4.

PMID:
18289825
16.

Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer.

Rauh-Hain JA, Rodriguez N, Growdon WB, Goodman AK, Boruta DM 2nd, Horowitz NS, del Carmen MG, Schorge JO.

Ann Surg Oncol. 2012 Mar;19(3):959-65. doi: 10.1245/s10434-011-2100-x. Epub 2011 Oct 13.

PMID:
21994038
17.

Interval debulking surgery for advanced epithelial ovarian cancer.

Tangjitgamol S, Manusirivithaya S, Laopaiboon M, Lumbiganon P.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006014. doi: 10.1002/14651858.CD006014.pub2. Review. Update in: Cochrane Database Syst Rev. 2009;(1):CD006014.

PMID:
18843699
18.

Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.

Muraji M, Sudo T, Iwasaki S, Ueno S, Wakahashi S, Yamaguchi S, Fujiwara K, Nishimura R.

Gynecol Oncol. 2013 Dec;131(3):531-4. doi: 10.1016/j.ygyno.2013.09.030. Epub 2013 Oct 4.

PMID:
24096109
19.

Contemporary considerations for neoadjuvant chemotherapy in primary ovarian cancer.

Schwartz PE.

Curr Oncol Rep. 2009 Nov;11(6):457-65. Review.

PMID:
19840523
20.

The position of neoadjuvant chemotherapy within the treatment of ovarian cancer.

Van Gorp T, Amant F, Neven P, Berteloot P, Leunen K, Vergote I.

Minerva Ginecol. 2006 Oct;58(5):393-403. Review.

PMID:
17006426
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk